Asheeta Prasad

Has grant

ARC Discovery Early Career Researcher

University of New South Wales
Country flagAustralia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Neurobiology of Deep Brain Stimulation of Parkinson's Disease

Open Date: 2019-01-01

Close Date: 2021-12-01

Grant: Close

Neural circuits of appetitive motivation

Open Date: 2017-01-01

Close Date: 2020-12-01

Grant: Close

Neural circuitry in Parkinsons Disease

Open Date: 2016-06-01

Close Date: 2017-06-01

Grant: Close

Career Advancement Fund

Open Date: 2015-06-01

Close Date:

Articles (6)

Year:

2026

Year:

2025

Alcohol use disorder (AUD) is a complex neurological disorder with limited treatments available. Thus, understanding the neurobiological changes associated with AUD is crucial for the development of effective therapeutic approaches. Analysis of human post‐mortem tissue provides insight into the long‐term effects of alcohol use and cellular changes that contribute to addiction behavior. Here, we provide a collection of cellular changes found in human AUD post‐mortem brain tissue, revealing brain region‐specific cellular adaptations that map a complex neurobiological landscape of addiction. Examination across the cortex, striatum, hippocampus, hypothalamus, cerebellum, and midbrain reveals that although degeneration, metabolic disruption, and neuroinflammatory processes are common cellular processes that are impacted, these changes are distinctive by brain region and cell type. For example, white matter loss dominates in the prefrontal cortex, the hippocampus is sensitive to glial cell loss, subtypes of hypothalamic neurons are disproportionately affected, and the striatum shows subregional changes. Although these cellular adaptations are brain region and cell type specific, this review of studies over the last 30 years suggests that neuropathology in AUD undergoes neural network reorganization. Whether these changes are a response to chronic alcohol use or underlying alcohol‐seeking behavior is a limitation of post‐mortem analysis. However, mechanistic studies of rodent models and convergent evidence from human post‐mortem tissue have identified therapeutic candidates such as oxytocin and GLP‐1. Insights from animal studies have also highlighted underexplored yet potentially pivotal regions in AUD, such as the anterior insular cortex and the ventral pallidum, in human studies. Other limitations include a lack of sex‐specific analyses, the incorporation of advanced neuroscience tools, and multiple regional analyses. Integrating AUD human post‐mortem tissue bridges preclinical and clinical research, providing an invaluable understanding of neural mechanisms underpinning AUD and potential avenues for targeted interventions. image

Year:

2025

Aims Parkinson’s disease is considered biologically a neuronal α-synuclein disease, largely ignoring the more widespread α-synuclein deposition that occurs in astrocytes, with the aim of this study to identify whether astrocytes accumulate small α-synuclein aggregates before or after neurons. Methods Fixed serial midbrain and striatal sections from M83 A53T transgenic mouse model of Parkinson’s disease and wild-type controls were histologically processed for multiplex labelling of α-synuclein and astrocytic markers and astrocyte quantitation performed on digital images using QuPath software. Results The density of astrocytes within the substantia nigra pars compacta was approximately 30% greater compared with other sampled regions ( P <0.005). Small aggregates of α-synuclein were observed in astrocytic processes, including in wild-type mice where a quarter of all astrocytes had an obvious α-synuclein aggregate. Compared to wild-type, A53T transgenic astrocytes had significantly enlarged somas ( P <0.001) with more processes ( P <0.001) consistent with a reactive phenotype. The A53T transgenic mice had more than double the numbers of astrocytes ( P <0.001) and 2.5 times more astrocytes with α-synuclein aggregates compared to wild-type mice ( P <0.001). Conclusions These data suggest that small α-synuclein aggregates are normally cleared by astrocytes and that the substantia nigra pars compacta requires more astrocytic support for this function than other midbrain dopaminergic regions or the striatum. This adds another vulnerability factor to those already known for the substantia nigra with early deficits in clearance of small α-synuclein aggregates by astrocytes associated with an increased astrocytic reactivity in the A53T transgenic mouse model. Key Points The substantia nigra pars compacta contains a higher density of astrocytes than the ventral tegmental area or striatum, indicating a greater reliance on astrocytic function and a greater vulnerability to astrocyte dysfunction Small aggregates of α-synuclein were observed in wild-type midbrain and striatal astrocytes, indicating normal clearance of α-synuclein by these astrocytes Midbrain and striatal astrocytes from A53T transgenic astrocytes have more than double the number of astrocytes and more astrocytes containing α-synuclein aggregates which have a reactive morphological phenotype.

Year:

2025

The subthalamic nucleus (STN) is a major neuromodulation target for the alleviation of neurological and neuropsychiatric symptoms using deep brain stimulation (DBS). STN-DBS is today applied as treatment in Parkinson´s disease, dystonia, essential tremor, and obsessive-compulsive disorder (OCD). STN-DBS also shows promise as a treatment for refractory Tourette syndrome. However, the internal organization of the STN has remained elusive and challenges researchers and clinicians: How can this small brain structure engage in the multitude of functions that renders it a key hub for therapeutic intervention of a variety of brain disorders ranging from motor to affective to cognitive? Based on recent gene expression studies of the STN, a comprehensive view of the anatomical and cellular organization, including revelations of spatio-molecular heterogeneity, is now possible to outline. In this review, we focus attention to the neurobiological architecture of the STN with specific emphasis on molecular patterns discovered within this complex brain area. Studies from human, non-human primate, and rodent brains now reveal anatomically defined distribution of specific molecular markers. Together their spatial patterns indicate a heterogeneous molecular architecture within the STN. Considering the translational capacity of targeting the STN in severe brain disorders, the addition of molecular profiling of the STN will allow for advancement in precision of clinical STN-based interventions.

Year:

2024

Year:

2024

Collaborators (6)

Richard Tan

Lecturer/Postdoctoral Research Officer

University of Sydney

AUSTRALIA
View details

Clare Parish

Florey Institute of Neuroscience and Mental Health

AUSTRALIA
View details

Åsa Mackenzie

Senior Lecturer

Lund University

SWEDEN
View details

David Finkelstein

Professor

University of Melbourne

AUSTRALIA
View details

Lachlan Thompson

Professor of Neuroscience

University of Sydney

AUSTRALIA
View details

Jennifer Cornish

Macquarie University

AUSTRALIA
View details